What Q3 Tells Us About The Stock Market In October

 | Oct 01, 2015 12:14AM ET

Three months ago, I served up a list of reasons for lowering one’s exposure to riskier assets. I discussed weakness in market internals where fewer and fewer corporate components of the Dow and S&P 500 had been propping up the popular U.S. benchmarks. I talked about the faster rate of deterioration in foreign stocks over domestic stocks via the Vanguard FTSE All-World (NYSE:VEU):S&P 500 SPDR Trust (NYSE:SPY) price ratio. Additionally, I highlighted exorbitant U.S. stock valuations, the Federal Reserve’s rate hike quagmire and the ominous risk aversion in credit spreads.

Three months later, a wide variety of risk assets are trading near 52-week lows or near year-to-date lows. Higher yielding bonds via PIMCO 0-5 Year High Yield Corporate (NYSE:HYS) as well as iShares iBoxx High Yield Bond (NYSE:HYG) are floundering in the basement. Energy via Equal Weight Energy (NYSE:RYE) has broken down below the S&P 500’s correction lows of August 24, suggesting that a bounce in oil and gas may be premature. Even former leadership in the beloved biotech sector via SPDR S&P Biotech Index (NYSE:XBI) reminds us that bearish drops of 33% can destroy wealth as quickly as it is accumulated.

Is it true that, historically speaking, bull market rallies typically fend off 10%-19% pullbacks? Absolutely. Yet there is nothing typical about zero percent rate policy for roughly seven years. For that matter, there was nothing normal about the U.S. Federal Reserve’s quantitative easing experiment – an emergency endeavor where $3.75 trillion in electronic dollar credits were used to acquire government debt and mortgage-backed debt. And ever since its 3rd iteration came to an end eleven months ago, broad market index investments like Vanguard Total Stock Market (NYSE:VTI) have lost ground.